(MedPage Today) — The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable gastric or gastroesophageal junction cancer, the agency announced on Tuesday.
Approval stipulates use of…
MSD India launches cervical cancer awareness initiative with Madhuri Dixit
Cervical cancer is one of the most common cancers affecting women in India; the campaign highlights key facts about cervical...





